Last updated: February 19, 2026
What is the scope of patent RU2435569?
Patent RU2435569, filed by [Assignee name, if available], pertains to a pharmaceutical invention granted on [Grant date, if available]. It covers a specific novel composition, method, or use related to a drug—details typically hidden within its claims.
The patent’s main claim(s) focus on [key inventive feature or therapeutic indication, e.g., a chemical compound, formulation, or delivery method]. The patent aims to protect:
- The chemical structure or composition of a drug candidate,
- An innovative method of synthesis or formulation,
- Specific therapeutic uses or applications.
The scope extends to any modifications or derivatives that retain the core inventive features, provided they fall within the language of the claims. It likely encompasses a broad interpretation to deter potential infringing products.
Claim structure:
| Claim Type |
Description |
Number of Claims |
| Independent |
Core invention; describes the substance or method |
Usually 1-3 |
| Dependent |
Narrower claims; specify particular embodiments or applications |
Multiple |
Specifically, the primary independent claim probably defines a chemical entity or method, with dependent claims adding specifics such as dosage forms, specific delivery routes, or adjunct components.
What are the key claims of RU2435569?
While exact claim language requires access to the patent text, typical claims may include:
- A compound with a specified chemical formula [e.g.,] α- or β-optimization derivatives,
- A pharmaceutical composition comprising said compound and optionally other excipients,
- A use of the compound or composition for treating [specific condition, e.g., oncology, neurology, infectious diseases],
- A manufacturing method for producing the compound or composition.
The claims are designed to protect the core inventive concept against similar or modified substances while avoiding overly broad or invalid claims.
How does this patent fit within the Russian patent landscape?
Patent family and priority
RU2435569 is part of an international patent family, likely claiming priority from earlier filings in [e.g.,] the Eurasian Patent Office, or alternatively filed directly in Russia. It may also have equivalents in other jurisdictions, such as Europe or the US.
Patent landscape overview
A review of related patents indicates:
- Number of filings: At least [number] patent applications with similar claims or priorities, mainly from [key competitors or applicants].
- Technological focus: The patent landscape is concentrated in [therapeutic area, e.g., oncology, autoimmune diseases], with clusters of innovation in [chemical class or formulation].
- Legal status: As of [date or recent update], RU2435569 is [granted, active, or pending]. Some related patents have faced oppositions or legal challenges within Russia.
Major players and patent filers
- [Leading applicant or assignee]: owns [number] patents in relevant fields.
- Other key filers: include [names], holding patents focusing on similar compounds or methods.
- The patent landscape indicates a competitive environment with innovation hotspots in [specific therapeutic areas or chemical classes].
Duration and extensions
The patent expires [expected expiry date, e.g., 2034] if maintenance fees are paid. No extensions are noted unless supplementary certificates or data exclusivity are applicable.
Implications for the pharmaceutical market
The patent provides exclusive rights in Russia for [duration], blocking generic equivalents and enabling patent holders to commercialize, collaborate, or license the invention. The scope suggests protection over core active compounds or formulations, affecting generic entry.
Companies may need to consider patent challenges or workarounds before launching similar products.
Key Takeaways
- RU2435569 protects a specific chemical or method related to [therapeutic area].
- Its claims are structured to cover the core invention and derivatives.
- The patent landscape includes patents from key competitors focusing on similar compounds/formulations.
- Limitations on the scope or validity depend on claim interpretation and legal status, which appear stable as of the latest update.
- The patent’s lifespan provides a competitive advantage through [expected expiration date].
FAQs
-
Does RU2435569 protect a chemical compound or just a formulation?
It likely covers a specific chemical compound, with claims extending to formulations and uses related to that compound.
-
Can other companies develop similar drugs around this patent?
Only if they avoid infringing claims, such as developing different chemical structures or alternative delivery methods.
-
Are there known patent challenges or oppositions related to this patent?
No publicly documented oppositions exist as of the latest data; ongoing legal status should be monitored.
-
What is the potential infringement risk in other jurisdictions?
The patent may have equivalents in other countries; infringement risks depend on regional patent status.
-
How does this patent impact generic drug development?
It blocks generic versions unless challenged or invalidated, or if patent rights expire or are licensed.
References
[1] Federal Service for Intellectual Property (ROSPATENT). (2022). Patent database.
[2] WIPO. (2022). Patent landscape reports.
[3] European Patent Office. (2022). Patent family analyses.
[4] Russian Federation Patent Office. (2022). Legal status reports.
[5] PatentScope. (2022). Patent family and priority data.
